201 related articles for article (PubMed ID: 22095497)
21. A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
Gao H; Deng S; Obach RS
Drug Metab Dispos; 2010 Dec; 38(12):2147-56. PubMed ID: 20847138
[TBL] [Abstract][Full Text] [Related]
22. Positive and negative electrospray ionisation travelling wave ion mobility mass spectrometry and low-energy collision-induced dissociation of sialic acid derivatives.
Winkler W; Huber W; Vlasak R; Allmaier G
Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3235-44. PubMed ID: 22006385
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of heterocyclic regioisomers: a combined tandem mass spectrometry and computational study of N-acridin-4-ylbenzylamide and N-acridin-2-yl-benzylamide.
Tintaru A; Benchabane Y; Boyer G; Humbel S; Charles L
Rapid Commun Mass Spectrom; 2008; 22(5):687-93. PubMed ID: 18265432
[TBL] [Abstract][Full Text] [Related]
24. Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers.
Liotta E; Gottardo R; Bertaso A; Polettini A
J Mass Spectrom; 2010 Mar; 45(3):261-71. PubMed ID: 20014151
[TBL] [Abstract][Full Text] [Related]
25. Miniaturized ultra high field asymmetric waveform ion mobility spectrometry combined with mass spectrometry for peptide analysis.
Brown LJ; Toutoungi DE; Devenport NA; Reynolds JC; Kaur-Atwal G; Boyle P; Creaser CS
Anal Chem; 2010 Dec; 82(23):9827-34. PubMed ID: 21049936
[TBL] [Abstract][Full Text] [Related]
26. Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs.
Tejada-Casado C; Hernández-Mesa M; Monteau F; Lara FJ; Olmo-Iruela MD; García-Campaña AM; Le Bizec B; Dervilly-Pinel G
Anal Chim Acta; 2018 Dec; 1043():52-63. PubMed ID: 30392669
[TBL] [Abstract][Full Text] [Related]
27. Tandem mass spectrometry of intact oxidation products of diacylphosphatidylcholines: evidence for the occurrence of the oxidation of the phosphocholine head and differentiation of isomers.
Reis A; Domingues P; Ferrer-Correia AJ; Domingues MR
J Mass Spectrom; 2004 Dec; 39(12):1513-22. PubMed ID: 15578637
[TBL] [Abstract][Full Text] [Related]
28. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.
Holcapek M; Kolárová L; Nobilis M
Anal Bioanal Chem; 2008 May; 391(1):59-78. PubMed ID: 18345532
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Nα-Fmoc-protected dipeptide isomers by electrospray ionization tandem mass spectrometry (ESI-MS(n)): effect of protecting group on fragmentation of dipeptides.
Ramesh M; Raju B; Srinivas R; Sureshbabu VV; Vishwanatha TM; Hemantha HP
Rapid Commun Mass Spectrom; 2011 Jul; 25(14):1949-58. PubMed ID: 21698678
[TBL] [Abstract][Full Text] [Related]
30. Collision Cross Sections and Ion Mobility Separation of Fragment Ions from Complex N-Glycans.
Harvey DJ; Watanabe Y; Allen JD; Rudd P; Pagel K; Crispin M; Struwe WB
J Am Soc Mass Spectrom; 2018 Jun; 29(6):1250-1261. PubMed ID: 29675741
[TBL] [Abstract][Full Text] [Related]
31. Tandem Mass Spectrometry and Ion Mobility Reveals Structural Insight into Eicosanoid Product Ion Formation.
Di Giovanni JP; Barkley RM; Jones DNM; Hankin JA; Murphy RC
J Am Soc Mass Spectrom; 2018 Jun; 29(6):1231-1241. PubMed ID: 29687419
[TBL] [Abstract][Full Text] [Related]
32. A rapid methodology for the characterization of dialkyl tertiary amine-N-oxide metabolites using structurally dependent dissociation pathways and reconstructed ion current chromatograms.
Holman SW; Wright P; Langley GJ
Anal Chem; 2010 Mar; 82(6):2347-54. PubMed ID: 20158225
[TBL] [Abstract][Full Text] [Related]
33. Utility of immonium ions for assignment of epsilon-N-acetyllysine-containing peptides by tandem mass spectrometry.
Trelle MB; Jensen ON
Anal Chem; 2008 May; 80(9):3422-30. PubMed ID: 18338905
[TBL] [Abstract][Full Text] [Related]
34. Structural resolution of carbohydrate positional and structural isomers based on gas-phase ion mobility-mass spectrometry.
Fenn LS; McLean JA
Phys Chem Chem Phys; 2011 Feb; 13(6):2196-205. PubMed ID: 21113554
[TBL] [Abstract][Full Text] [Related]
35. Carbohydrate structure characterization by tandem ion mobility mass spectrometry (IMMS)2.
Li H; Bendiak B; Siems WF; Gang DR; Hill HH
Anal Chem; 2013 Mar; 85(5):2760-9. PubMed ID: 23330948
[TBL] [Abstract][Full Text] [Related]
36. Ion mobility mass spectrometry analysis of human glycourinome.
Vakhrushev SY; Langridge J; Campuzano I; Hughes C; Peter-Katalinić J
Anal Chem; 2008 Apr; 80(7):2506-13. PubMed ID: 18269265
[TBL] [Abstract][Full Text] [Related]
37. Analytical strategies for identifying drug metabolites.
Prakash C; Shaffer CL; Nedderman A
Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
[TBL] [Abstract][Full Text] [Related]
38. Collision-induced fragmentation pathways including odd-electron ion formation from desorption electrospray ionisation generated protonated and deprotonated drugs derived from tandem accurate mass spectrometry.
Williams JP; Nibbering NM; Green BN; Patel VJ; Scrivens JH
J Mass Spectrom; 2006 Oct; 41(10):1277-86. PubMed ID: 16983735
[TBL] [Abstract][Full Text] [Related]
39. Travelling-wave ion mobility mass spectrometry and negative ion fragmentation of hybrid and complex N-glycans.
Harvey DJ; Scarff CA; Edgeworth M; Pagel K; Thalassinos K; Struwe WB; Crispin M; Scrivens JH
J Mass Spectrom; 2016 Nov; 51(11):1064-1079. PubMed ID: 27477117
[TBL] [Abstract][Full Text] [Related]
40. Use of liquid chromatography/tandem mass spectrometric molecular fingerprinting for the rapid structural identification of pharmaceutical impurities.
Li M; Wang X; Chen B; Lin M; Buevich AV; Chan TM; Rustum AM
Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3533-42. PubMed ID: 19844969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
